Search Results
Site Search
Hereditary peripheral neuropathy - Insights
Learn how our test menu can assist in identifying genetic causes across the spectrum of hereditary peripheral neuropathies.
Testing Options for Patients with Chronic Diarrhea: A Focus on Bile Acid Malabsorption - Insights
A new serum test for bile acid malabsorption. Descriptions illustrate how the test can be used as a screening test and as a tool for therapeutic action.
MCL @Work: Ben Levno - Insights
As a senior product manager for Mayo Clinic Laboratories, Ben Levno supports the neurology segment of specialty testing. While Mayo Clinic physicians have access to our world-renowned neurology testing to diagnose and care for patients,...
Mayo Clinic Labs @Work: Cara Ryan - Insights
As director of Contract Administration, Cara Ryan’s work spans a diverse range of activities that connect with a variety of groups across the organization, all with a goal of supporting patient care.
What's New in Health Care Reform: Jan. 16 - Insights
Top highlights include: Up to 84,000 Americans hospitalized with flu in past three months, scientists seek real way to measure, severe flu raises risk of birth problems for pregnant women, babies, deep sleep linked to early Alzheimer's...
Autoimmune testing education - Insights
Mayo Clinic Laboratories is leading an evolution in autoimmune neurology diagnosis. Powered by expertise from our research labs, clinical labs, and Autoimmune Neurology Clinic, we have developed panels customized to address specific...
MCL PhenotypeSpecific Testing for Autoimmune and Paraneoplastic Etiologies Poster MC2775455
MCL PhenotypeSpecific Testing Autoimmune Paraneoplastic Etiologies Poster NEUROLOGY PHENOTYPE SPECIFIC TESTING AUTOIMMUNE PARANEOPLASTIC ETIOLOGIES Powered expertise research labs clinical labs Autoimmune
In a recent issue of Mayo Clinic's Digestive Diseases, Michael Camilleri, M.D., a gastroenterologist at Mayo Clinic, and Leslie Donato, Ph.D., Co-Director for Cardiovascular Laboratory Medicine, Hospital Clinical Laboratory, and Point of...
Leveraging Lessons from the Past - Insights
Sharing lessons learned from past process improvement and other projects conducted at Mayo Clinic.
Week in Review: May 6 - Insights
Today's highlights include: Mental health needs rise as pandemic fluctuates, an algorithm that analyzes apple watch data shows early promise in detecting heart problems, and Minnesota physicians brace for Roe v. Wade decision
Assay enhances and simplifies M-proteins screening: David Murray, M.D., Ph.D. - Insights
David Murray, M.D., Ph.D., explains how Mayo Clinic Laboratories' MASSFIX Quantitation assay provides next-generation screening for M-proteins, which are associated with multiple myeloma and other diseases. The assay better quantitates the...
Dr. Dong Chen and Dr. Sounak Gupta joined the “Becker’s Healthcare Podcast” to discuss the molecular testing space and its important role in personalized cancer treatment. Dr. Chen and Dr. Gupta highlighted the importance of selecting the...
MAG Antibody Testing [Test in Focus] - Insights
John Mills, Ph.D., explains Mayo Clinic Laboratories’ approach to MAG antibody testing. The ELISA-based assay uses higher reference ranges and human MAG antigen to detect MAG antibodies, which are associated with a rare, hard-to-treat...
Autoimmune evolution - Insights
Mayo Clinic Laboratories is leading an evolution in autoimmune neurology diagnosis. To better reflect this testing evolution, and to reduce confusion and improve utilization for our clients, effective April 28, we are renaming our...
Mayo Clinic Labs @Work - Insights
Behind the scenes of a global lab Thousands of people in hundreds of different roles work at Mayo Clinic Laboratories. Mayo Clinic Labs @Work offers a
Our staff, our stories: Patrice Brown - Insights
Patrice Brown, PA(ASCP), shares her story of growing up in Virginia and moving to Rochester, Minnesota to work at Mayo Clinic. She also shares her unique perspective of traveling internationally as COVID-19 was starting to spread.
People Archives - Page 31 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
Reclaiming her joy: Joy Carol - Insights
A tenacious fighter, Joy Carol never lost hope that a mysterious condition that had stripped her of her ability to move would be identified. Hope turned into reality when a Mayo Clinic Laboratories test identified the cause of her illness...
Encephalitis caused by the immune system attacking the brain is similar in frequency to encephalitis from infections, Mayo Clinic researchers report in Annals of Neurology.
Ticks and the Art of Finding Beauty in Dreadful, Wonderful Parasites - Insights
Bobbi Pritt, M.D., spends her work hours identifying and diagnosing infectious diseases. In her free time, she celebrates their beauty by creating bug-related artwork and blogging about parasites.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Our suite of preeclampsia, prenatal, breast and gynecological cancer, and other testing has been developed in collaboration with clinical leaders in a variety of women’s health specialties to provide accurate, actionable results.
Colorectal Cancer NGS Testing - Mayo Clinic Laboratories
Our panel was designed to meet current guidelines and remain targeted enough to provide clinically actionable results.
Lung Cancer NGS Panel - Mayo Clinic Laboratories
Our targeted lung cancer panel assesses for mutations in eight genes, and rearrangements in four genes, including those recommended by the National Comprehensive Cancer Network: EGFR, ROS1, BRAF, and ALK.
Future Direction of Lab Medicine - Insights
Looking into the future of laboratory medicine and pathology and providing insight into the direction its heading.
Browse our menu of MayoComplete next-generation sequencing assays which are designed to identify a growing list of hematological cancers.
Learn about our full suite of leukemia testing protocols, including includes flow cytometry, chromosome, FISH, and molecular testing.
The Phlebotomy Resource Page is a compilation of on demand content, presentations, and other phlebotomy-related education.
An efficient, cost-effective, fungal testing alternative: Elitza Theel, Ph.D. - Insights
Elitza Theel, Ph.D., explains how Mayo Clinic Laboratories' unique Histoplasma/Blastomyces test provides cost-effective evaluation for fungal infections that cause pulmonary illness. The assay reliably detects both Histoplasma and...
NELL-1 [Test in Focus] - Insights
Sanjeev Sethi, M.D., Ph.D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic certainty and...
Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC, explain how Mayo Clinic Laboratories' gene panel establishes a diagnosis of Lynch syndrome, which heightens the risk for several cancers. Test results can guide targeted cancer surveillance for...
Zhiyv (Neal) Niu, Ph.D., and Rodolfo Savica, M.D., Ph.D., explain why Mayo Clinic Laboratories' gene panel is the most comprehensive test available for inherited Parkinson's disease. The new panel covers all mutations known to cause the...
The Resources page features a compilation of valuable education and content not specific to a program type.
A repository of Phlebotomy related education.
Mayo Clinic researchers identify new disease subtype linked to recurrent blood clots - Insights
Mayo Clinic researchers identify a new subtype of MGTS, linked to recurrent blood clots, with significant diagnostic challenges and treatment implications.
Addiction rehab monitoring assay - Insights
Paul Jannetto, Ph.D., and Loralie Langman, Ph.D., discuss Mayo Clinic Laboratories' unique approach to urine drug testing for addiction rehabilitation. Designed to guide and monitor therapy, the comprehensive profile tests for the most...
Alzheimer's Disease 2024: The Role of Biomarkers - Insights
PACE/State of FL - The latest updates in Alzheimer’s disease diagnostic criteria as well as a comprehensive review of the laboratory testing landscape.
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous thromboembolism.
Mayo Clinic MASSFIX - Insights
Learn more about matrix-assisted laser desorption/ionization-time of flight mass spectrometry and the identification of plasma cell disorders.
Updated Test Promises Fewer False Positives in Newborn Screening for Krabbe Disease - Insights
Mayo Clinic’s Biochemical Genetics Laboratory has announced an updated second-tier test to detect Krabbe disease (KD) that uses psychosine (PSY) as a disease marker. The new test method has significantly higher sensitivity to detect this...
Osmotic fragility testing - Insights
In this month’s “Hot Topic,” James Hoyer, M.D., discusses the importance of using a control tube during osmotic fragility testing.
Phlebotomy Top Gun: Order of Draw-Do We Still Care? - Insights
In this month’s “Hot Topic,” Brad Karon, M.D., Ph.D., will cover the need and evidence behind following the order of draw recommendations for routine blood collection. Specifically, does evidence demonstrate a need to collect serum tubes...
Mayo Clinic Laboratory and Pathology Research Roundup: March 12 - Insights
This week’s Research Roundup highlights cardiovascular concerns in BRCA1 and BRCA2 mutation carriers.